Browsing by Author Osborne, Aaron

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2014Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab TreatmentMitchell, Paul; Rochtchina, Elena; Bressler, Neil; Colman, Shoshana; Danese, Mark; Doan, Quan V; Dolan, Chantal; Ferreira, Alberto; Osborne, Aaron; Wong, Tien; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Clinical Ophthal & Eye HealthEstimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment, PloS One, vol.9, 6, 2014,pp 1-8
2013Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programmeGillies, Mark; Mitchell, Paul; Bandello, Francesco; Figueroa, Marta S; Holz, Frank; Osborne, Aaron; Sheidow, Tom; Souied, Eric; Central Clinical School: Save Sight & Eye Health Inst.; Western Clinical School: Westmead Millennium InstituteSafety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme, The British Journal of Ophthalmology, vol.97, 9, 2013,pp 1161-1167
2014Three-Year Outcomes of Individual Ranibizumab Treatment in Patients with Diabetic Macular Edema. The RESTORE Extension StudyMitchell, Paul; Bouazza, Abdelkader Si; Gerstner, Ortrud; Holz, Frank; Lang, Gabriele E.; Lanzetta, P; Massin, Pascale; Osborne, Aaron; Schlingemann, Reinier O.; Schmidt-Erfurth, U; Shen, Haige; Western Clinical School: Westmead Millennium InstituteThree-Year Outcomes of Individual Ranibizumab Treatment in Patients with Diabetic Macular Edema. The RESTORE Extension Study, Ophthalmology, vol.121, 5, 2014,pp 1045-1053